[go: up one dir, main page]

CN101012264A - Method of synthesizing pig ectohormone - Google Patents

Method of synthesizing pig ectohormone Download PDF

Info

Publication number
CN101012264A
CN101012264A CN 200710037402 CN200710037402A CN101012264A CN 101012264 A CN101012264 A CN 101012264A CN 200710037402 CN200710037402 CN 200710037402 CN 200710037402 A CN200710037402 A CN 200710037402A CN 101012264 A CN101012264 A CN 101012264A
Authority
CN
China
Prior art keywords
compound
solvent
porcine
synthesizing
pheromone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200710037402
Other languages
Chinese (zh)
Other versions
CN100482675C (en
Inventor
田伟生
许启海
李伯玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CNB2007100374029A priority Critical patent/CN100482675C/en
Publication of CN101012264A publication Critical patent/CN101012264A/en
Application granted granted Critical
Publication of CN100482675C publication Critical patent/CN100482675C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

本发明涉及一种合成猪外激素的方法。以自然界广泛存在的剑麻皂甙元的降解产物——孕甾三醇为原料,完成了猪外激素雄甾-16-烯-3-酮和雄甾-16-烯-3α-醇的合成。本发明的方法操作简便、试剂价格低廉、产物收率高,适合工业化生产,这种方法实现了甾体皂甙元的降解产物——孕甾醇的进一步有效利用。

The invention relates to a method for synthesizing porcine pheromone. The synthesis of porcine pheromones androst-16-en-3-one and androst-16-en-3α-ol was completed using gragnatriol, a degradation product of sisal sapogenin that exists widely in nature, as raw materials. The method of the invention has the advantages of simple operation, low reagent price and high product yield, and is suitable for industrial production. The method realizes the further effective utilization of the degradation product of steroidal sapogenin—pregnanol.

Description

A kind of method of synthesizing pig ectohormone
Technical field
The present invention relates to a kind of method of synthesizing pig ectohormone.The sisalagenin that extensively exists with nature is a basic raw material, has finished synthesizing of pig ectohormone rost-16-en-3-one and androstane-16-alkene-3 α-alcohol by 5 step reactions and the reaction of 6 steps respectively, and is shorter, easy and simple to handle than existing literature method step, yield is high.
Technical background
Contain rost-16-en-3-one (1) and androstane-16-alkene-3 α-alcohol (2) in the urine of boar, they are known two kinds of pig ectohormones, can induce the sexual behaviour of sow, shorten the oestrus cycle, and can when artificial insemination, be used to detect the breeding reaction of pig, improve conception rate, had in the pig industry abroad and used (China Medicine University's journal more widely, 1991,22,367).What is interesting is, in the sweat of man oxter, also found compound 1 (Proc.Int.Symp.Olfaction Taste, 7th, 1980,397-400; CA, 1981,94:115047), and also influential to people's behavior.
These two compounds are the synthetic key intermediate androstane of raw material-16-alkene-3 β-alcohol (4) with epiandrosterone (3) generally, and then obtain through peroxidation or counter-rotating 3-position hydroxyl.Synthetic route (TetrahedronLett., 1962,26,1261 as follows relatively more commonly used at present; Acta Pharmaceutica Sinica, 1982,17,696):
Figure A20071003740200041
Epiandrosterone 3 industrial be to be raw material with the cheap diosgenin diosgenin that gets bumper crops, obtain through degraded and hydrogenation, i.e. sapogenin and Ac in autoclave 2O is heated to 200 ℃ and is cracked into false steroid sapogenines, again through chromic anhydride oxidation, elimination reaction and rearrangement reaction preparation (J.Am.Chem.Soc., 1940,62,3350; J.Org.Chem., 1956,21,520), severe reaction conditions, complex operation, particularly chromic anhydride oxidation pollute very serious in process of production:
Figure A20071003740200051
a,Ac 2O,200℃;b,CrO 3;c,NaOAc;d,NH 2OH;e,POCl 3;f,K 2CO 3,MeOH;g,H 2,cat.。
Tian Weisheng group has developed method (Chinese patent, the ZL96116304.6 that becomes pregnen alcohol, steroidal lactone, Progesterone and Androstanediol with hydrogen peroxide degradation of steroid sapogenin; Chinese patent, ZL00127974.2; Chinese patent, ZL01113196.9; Chinese patent, ZL03141641.1), new degradation method has not only been eliminated the problem of environmental pollution of the heavy metal chromium that exists in the classical degradation method, has also improved the availability of steroid sapogenines and the yield of degraded product simultaneously.On this basis, developed pregnant steroid-3,16, the regioselectivity acetylize bromo-reaction of 20-triol (Chinese patent ZL200610024097.5), obtains 20-glycolic acid esters-16 alpha-bromo-sterides 5:
Figure A20071003740200052
Bibliographical information, steroidal-20-hydroxyl-16-sulphonate can chipping rearrangement obtain androstane-16-alkene-3 β-alcohol, but the product complexity, the yield of androstane-16-alkene-3 β-alcohol lower (J.Org.Chem., 1970,35,561):
Figure A20071003740200053
Ts is a p-toluenesulfonyl, and Ms is a methylsulfonyl.
The contriver wishes that the sisalagenin to obtain in the industrial pollutent of China system fiber crops is a raw material, use the patented technology of the conversion sisalagenin that we have developed, synthetic key intermediate androstane-16-alkene-3 β-alcohol (4) and pig ectohormone compound 1 and compound 2.
Summary of the invention
The novel method that the purpose of this invention is to provide a kind of synthesizing pig ectohormone.
Synthetic route of the present invention is as follows:
Figure A20071003740200061
The method of starting compound 5 reference synthetic (Chinese patent, ZL200610024097.5).
The concrete operations step is as follows:
1) in polar solvent, 20-glycolic acid esters-16 alpha-bromo-sterides 5 reacted 0.5-50 hour under reflux temperature in room temperature with alkali, obtained 20-hydroxy-16 alpha--bromo steroidal compounds 6; Compound 5 is 1: 0.01~20 with the mol ratio of alkali; Described alkali is LiOH, NaOH, KOH, MeONa, EtONa, Li 2CO 3, Na 2CO 3, K 2CO 3, Cs 2CO 3, NaHCO 3Or KHCO 3Be recommended as in methyl alcohol and K 2CO 3Reaction; Reaction times is recommended as 5-15 hour; Compound 5 is recommended as 1: 0.5 with the mol ratio of alkali~and 5;
2) 20-hydroxy-16 alpha--bromo steroidal compounds 6 or its are dissolved in the solution in the polar solvent, join in polar solvent and the alkaline mixture under reflux temperature at-78 ℃, react 0.2-24 hour, obtain androstane-16-alkene-3 β-alcohol 4; Compound 6 is 1: 0.5~50 with the alkaline mol ratio; Described highly basic is NaOH, KOH, KH, NaH, NaNH 2, LiNH 2, hexamethyl two silica-based potassium amides (KHMDS), hexamethyl two silica-based sodium amides (NaHMDS), hexamethyl two silica-based Lithamides (LiHMDS), lithium diisopropylamine (LDA), MeLi, n-BuLi, s-BuLi, t-BuLi, MeONa, EtONa or potassium tert.-butoxide (t-BuOK), be recommended as potassium tert.-butoxide; Reaction times is recommended as 5-15 hour; Compound 6 is recommended as 1: 1 with the alkaline mol ratio~and 5;
3) compound 4 is dissolved in the solvent, adds oxygenant and assistant agent, at-78~60 ℃ of reaction 0.1~24h, obtains compound 1, and compound 4 is 1: 1~10: 0~15 with the mol ratio of oxygenant and assistant agent; Described oxygenant is Na 2Cr 2O 7, CrO 3, pyridinium chloro-chromate (PCC), pyridinium dichromate (PDC), MnO 2, KMnO 4, dimethyl sulfoxide (DMSO) (DMSO) or Dai Si-Martin (Dess-Martin) oxygenant; Described assistant agent is NaOAc, KOAc, Na 2CO 3, NaHCO 3, H 2SO 4, acetate, oxalyl chloride, triethylamine, pyridine sulphur trioxide (SO 3Py), pyridine or their mixture; Be recommended as in acetone with Jones reagent (CrO 3-H 2SO 4-H 2O) carry out oxidation; Reaction times is recommended as 0.1-5 hour; When not having assistant agent, compound 4 is recommended as 1: 1 with the mol ratio of oxygenant~and 5; When assistant agent, compound 4 is recommended as 1: 1 with the mol ratio of oxygenant and assistant agent~and 5: 1~5;
4) in organic solvent, compound 1 reacted 0.5~15 hour at-78~50 ℃ with reductive agent, got compound 2; Compound 1 is 1: 0.5~15 with the mol ratio of reductive agent; Described reductive agent is NaBH 4, sodium cyanoborohydride (NaBH 3CN), KBH 4, LiBH 4, ZnBH 4, aluminum isopropylate, diisobutyl aluminium hydride (DIBALH), lithium triethylborohydride (LiBHEt 3), 3-sec-butyl lithium borohydride (L-Selectride), three sec-butyl POTASSIUM BOROHYDRIDE (K-Selectride), triisopentyl lithium borohydride (Ls-Selectride) or triisopentyl POTASSIUM BOROHYDRIDE (Ks-Selectride), be recommended as L-Selectride, K-Selectride, Ls-Selectride or Ks-Selectride; When reductive agent is triisopentyl lithium borohydride and solvent when being tetrahydrofuran (THF), the reaction times can not be 3 hours; Reaction times is recommended as 0.5-5 hour; Compound 1 is recommended as 1: 1 with the mol ratio of reductive agent~and 5.
Polar solvent described in the above-mentioned reaction is alcoholic solvent, acetone, water, tetrahydrofuran (THF) (THF), 1,4-diox (dioxane), acetonitrile, dimethyl sulfoxide (DMSO) (DMSO), N, the mixed solvent of dinethylformamide (DMF), N,N-dimethylacetamide (DME) or their compositions; Described solvent is H 2O, acetate, the trimethyl carbinol (t-BuOH), non-protonic solvent or their mixture; Described organic solvent is non-protonic solvent, alcoholic solvent or their mixture; Described non-protonic solvent is CH 2Cl 2, CHCl 3, CCl 4, 1,2-ethylene dichloride, tetrahydrofuran (THF) (THF), ether, 1,4-diox, acetonitrile, acetone, sherwood oil (PE), normal hexane, benzene, toluene, methyl-sulphoxide (DMSO), N, dinethylformamide (DMF), pyridine or their mixture; Described alcoholic solvent is methyl alcohol, ethanol, propyl alcohol, Virahol, butanols, isopropylcarbinol, sec-butyl alcohol, the trimethyl carbinol or their mixture.
The present invention has following advantage:
1. with the steroid sapogenines basic raw material, by degraded, bromo, remove key intermediate androstane-16-alkene-3 β-alcohol that ethanoyl and fragmentation reaction have obtained synthesizing pig ectohormone.This synthesis strategy has utilized the new degradation method of steroid sapogenines, has avoided the with serious pollution problem of chromic anhydride degraded.
2. the method for the synthetic rost-16-en-3-one of the present invention and androstane-16-alkene-3 α-alcohol is easy and simple to handle, reagent is cheap, product yield is high.
Specific implementation method
To help to understand the present invention by following specific implementation method, but not limit content of the present invention.
The method of compound 5 reference literatures of the present invention synthetic (Chinese patent, ZL200610024097.5).
Synthesizing of embodiment 1 compound 6
Figure A20071003740200081
Take by weighing 500mg compound 5 and be dissolved in an amount of MeOH, add 429mg (3eq.) K 2CO 3The reaction that is hydrolyzed, 43 ℃ of reactions 10 hours.Concentrate near doing, ethyl acetate is collected residue, and organic phase is washed with saturated common salt, and anhydrous magnesium sulfate drying leaves standstill 30min, filters, and revolves the steaming ethyl acetate, and column chromatography is got 178mg compound 6 (89.2%).
Compound 6, mp168 ℃, [α] 25 D+ 9.2 (c 0.765, CHCl 3); 1H-NMR (CDCl 3, 400MHz) δ: 0.63 (s, 3H, 18-H), 0.85 (s, 3H, 19-H), 3.33 (m, 1H, 3-H) 3.74 (m, 1H, 20-H), 4.42 (m, 1H, 16-H); IRv:3415,2921,2847,1442,1372,1041cm -1Ultimate analysis calculated value C 25H 39O 4Br:C63.15, H 8.83; Measured value C 63.36, H 8.47.
Synthesizing of embodiment 2 compounds 4
200mg compound 6 and 281mg (5eq.) the t-BuOK 7h that refluxes in t-BuOH, raw material disappears.Add shrend and go out, ethyl acetate extraction, saturated common salt water washing 2 times of the organic phase of merging, anhydrous magnesium sulfate drying.Filter, concentrate, the resistates column chromatography for separation gets product 4 65mg (47.2%).
Compound 4, mp127 ℃; [α] 25 D+ 13.3 (c 1.30, CHCl 3); 1H-NMR (CDCl 3, 300MHz) δ: 5.83 (d, J=3.9Hz, 1H, 16-H), 5.69 (br s, 1H, 17-H), 3.66-3.54 (m, 1H, 3-H), 0.84 (s, 3H, 18-H), 0.75 (s, 3H, 19-H); 13C-NMR (CDCl 3, 80 MHz) and δ: 144.19; 129.51; 71.52; 56.33; 55.42; 45.80; 45.31; 38.44; 37.08; 36.17; 36.00; 34.34; 32.36; 32.248; 31.74; 28.93; 21.45; 17.31; 12.57; IRv:3346,3040,2938,2844cm -1.
Synthesizing of embodiment 3 compounds 1
Method one (Jones reagent oxidation):
1.7g (6.2mmol) compound 4 is dissolved among the acetone 100mL, splashes into Jones reagent (CrO 3-H 2SO 4-H 2O) do not disappear (about 1.0eq.) until redness, use the methyl alcohol cancellation after 5 minutes, inclining liquid, the residue washing with acetone, and the liquid concentration of merging, ethyl acetate is collected resistates, and organic phase is water and saturated NaHCO respectively 3Wash, dried over sodium sulfate is filtered, and concentrates, and column chromatography gets 1.477g compound 1 (88%).
Method two (Dess-Martin) oxidation):
1.0mmol compound 4 is dissolved in CH 2Cl 2Among the 10mL, add the Dess-Martin oxygenant of 1.5eq., be stirred to raw material and disappear, use saturated NaHCO 3And Na 2S 2O 3Cancellation, ethyl acetate extraction, the saturated common salt water washing of the organic phase of merging, dried over sodium sulfate is filtered, and concentrates, and column chromatography gets compound 1 (91%).
Compound 1, C 19H 28O; FW 272; HPLC 99.80%; Mp142-143 ℃; [α] 24.7 D+ 38.9 (c 1.14, CHCl 3); 1H-NMR (CDCl 3, 300MHz) δ: 5.85 and 5.70 (each br s, 2H, 16-and 17-H), 1.06 (s, 3H, 19-H), 0.80 (s, 3H, 18-H); IR v:2952,1712,1443,719cm -1.
Synthesizing of embodiment 4 compounds 2
Figure A20071003740200092
Method one (synthetic by compound 1 reduction, the method for fractional steps):
0.224g (0.82mmol) compound 1 is dissolved among the tetrahydrofuran (THF) 5mL,-60 ℃ splash into L-Selectride 1.12mL 1M (2.5mol 1.36eq.), rise to room temperature, reacted 1 hour, be cooled to-60 ℃ again, add 0.5mL water and 1.5mL ethanol successively, add 0.5mL 50% aqueous sodium hydroxide solution and 1.5mL 30% hydrogen peroxide then successively, rise to room temperature, stirred 3 hours, and added the 100mL ethyl acetate, organic phase washes with water successively, saturated NaHSO 3With saturated common salt water washing, dried over sodium sulfate, filter, concentrate, column chromatography gets 0.168g compound 2 (74.5%).
Method two (synthetic by one pot of compound 4 oxidation-reduction, one kettle way):
3.58g (13.1mmol) compound 4 is dissolved among the acetone 150mL, splashes into Jones reagent and does not disappear (about 1.0eq.) until redness, uses the methyl alcohol cancellation after 5 minutes, inclining liquid, residue washing with acetone, the liquid concentration of merging, ethyl acetate is collected resistates, and organic phase is water and saturated NaHCO respectively 3Wash, dried over sodium sulfate, filter, concentrate, the crude product of vacuum suction gained compound 1 is dissolved in the 40mL tetrahydrofuran (THF),-60 ℃ splash into L-Selectride 17mL 1M (1.36eq.), rise to room temperature, reacted 1 hour, be cooled to 0 ℃ again, add 5mL water and 5mL ethanol successively, add 5mL 50% aqueous sodium hydroxide solution and 21mL 30%H then successively 2O 2, rise to room temperature, stirred 3 hours, add the 200mL ethyl acetate, organic phase washes with water successively, saturated NaHSO 3With saturated common salt water washing, dried over sodium sulfate, filter, concentrate, column chromatography gets 2.632g compound 2 (73.5%for two steps), receives 0.525g compound 4 (14.7%) and 0.023g compound 1 (0.7%) in addition.
Compound 2, C 19H 30O; FW 274; HPLC 99.99%; Mp144-145 ℃; [α] 24.6 D+ 14.3 (c 1.24, CHCl 3); 1H-NMR (CDCl 3, 300MHz) δ: 5.85 (m, 1H, 16-H), 5.69 (m, 1H, 17-H), 4.05 (br s, 1H, 3-H), 0.82 (s, 3H, 18-H), 0.75 (s, 3H, 19-H); IR v:3294,2932,1451,1001,715cm -1.

Claims (6)

1、一种合成猪外激素的方法,其特征是通过如下1)~6)的步骤获得:1. A method for synthesizing porcine pheromone, characterized in that it is obtained through the steps of 1) to 6): 1)在极性溶剂中,20-羟基乙酸酯-16α-溴代甾体化合物5与碱在室温到回流温度下反应0.5-50小时,得到20-羟基-16α-溴代甾体化合物6;化合物5与碱的摩尔比为1∶0.01~20;所述的碱为LiOH、NaOH、KOH、MeONa、EtONa、Li2CO3、Na2CO3、K2CO3、Cs2CO3、NaHCO3或KHCO31) In a polar solvent, react 20-hydroxyacetate-16α-bromosteroid compound 5 with a base at room temperature to reflux temperature for 0.5-50 hours to obtain 20-hydroxyl-16α-bromosteroid compound 6 ; The molar ratio of compound 5 to base is 1:0.01~20; the base is LiOH, NaOH, KOH, MeONa, EtONa, Li 2 CO 3 , Na 2 CO 3 , K 2 CO 3 , Cs 2 CO 3 , NaHCO3 or KHCO3 ; 2)20-羟基-16α-溴代甾体化合物6或其溶解在极性溶剂中的溶液,在-78℃到回流温度下加入到极性溶剂与强碱的混合物中,反应0.2-24小时,得到雄甾-16-烯-3β-醇4;化合物6与强碱的摩尔比为1∶0.5~50;所述的强碱为NaOH、KOH、KH、NaH、NaNH2、LiNH2、六甲基二硅基氨基钾、六甲基二硅基氨基钠、六甲基二硅基氨基锂、二异丙基氨基锂、MeLi、n-BuLi、s-BuLi、t-BuLi、MeONa、EtONa或者叔丁醇钾;2) 20-hydroxyl-16α-bromo steroidal compound 6 or its solution dissolved in polar solvent is added to the mixture of polar solvent and strong base at -78°C to reflux temperature, and reacted for 0.2-24 hours , to obtain androst-16-ene-3β-ol 4; the molar ratio of compound 6 to strong base is 1:0.5~50; the strong base is NaOH, KOH, KH, NaH, NaNH 2 , LiNH 2 , six Potassium methyldisilazide, sodium hexamethyldisilazide, lithium hexamethyldisilazide, lithium diisopropylamide, MeLi, n-BuLi, s-BuLi, t-BuLi, MeONa, EtONa or potassium tert-butoxide; 3)化合物4溶解在溶剂中,加入氧化剂和辅剂,在-78~60℃反应0.1~24h,得到化合物1,化合物4与氧化剂及辅剂的摩尔比是1∶1~10∶0~15;所述的氧化剂是Na2Cr2O7、CrO3、氯铬酸吡啶盐、重铬酸吡啶盐、MnO2、KMnO4、二甲基亚砜或戴斯-马丁氧化剂;所述的辅剂是NaOAc、KOAc、Na2CO3、NaHCO3、H2SO4、乙酸、草酰氯、三乙胺、吡啶三氧化硫、吡啶或它们的混合物;3) Dissolve compound 4 in a solvent, add oxidizing agent and auxiliary agent, and react at -78-60°C for 0.1-24 hours to obtain compound 1. The molar ratio of compound 4 to oxidizing agent and auxiliary agent is 1:1-10:0-15 ; The oxidant is Na 2 Cr 2 O 7 , CrO 3 , pyridinium chlorochromate, pyridinium dichromate, MnO 2 , KMnO 4 , dimethyl sulfoxide or Dess-Martin oxidant; the auxiliary The agent is NaOAc, KOAc, Na 2 CO 3 , NaHCO 3 , H 2 SO 4 , acetic acid, oxalyl chloride, triethylamine, pyridine sulfur trioxide, pyridine or their mixtures; 4)在有机溶剂中,化合物1与还原剂在-78~50℃反应0.5~15小时,得化合物2;化合物1与还原剂的摩尔比是1∶0.5~15;所述的还原剂是NaBH4、氰基硼氢化钠、KBH4、LiBH4、ZnBH4、异丙醇铝、二异丁基氢化铝、三乙基硼氢化锂、三仲丁基硼氢化锂、三仲丁基硼氢化钾、三异戊基硼氢化锂或者三异戊基硼氢化钾;当还原剂为三异戊基硼氢化锂且溶剂为四氢呋喃时,反应时间不能为3小时;4) In an organic solvent, react Compound 1 with a reducing agent at -78 to 50° C. for 0.5 to 15 hours to obtain Compound 2; the molar ratio of Compound 1 to the reducing agent is 1: 0.5 to 15; the reducing agent is NaBH 4. Sodium cyanoborohydride, KBH 4 , LiBH 4 , ZnBH 4 , aluminum isopropoxide, diisobutylaluminum hydride, lithium triethylborohydride, lithium tri-sec-butyl borohydride, tri-sec-butyl borohydride Potassium, lithium triisopentyl borohydride or potassium triisopentyl borohydride; when the reducing agent is lithium triisopentyl borohydride and the solvent is tetrahydrofuran, the reaction time cannot be 3 hours; 所述的化合物1、2、4~6的结构式如下所示:The structural formulas of the compounds 1, 2, 4-6 are as follows:
Figure A2007100374020002C1
Figure A2007100374020002C1
2、如权利要求1所述的猪外激素的合成方法,其特征是所述的极性溶剂是醇类溶剂、丙酮、水、四氢呋喃、1,4-二噁烷、乙腈、二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺或者它们组成的混合溶剂。2, the synthetic method of porcine pheromone as claimed in claim 1 is characterized in that described polar solvent is alcoholic solvent, acetone, water, tetrahydrofuran, 1,4-dioxane, acetonitrile, dimethylmethylene Sulfone, N,N-dimethylformamide, N,N-dimethylacetamide or their mixed solvents. 3、一种如权利要求1所述的猪外激素的合成方法,其特征是所述的溶剂是H2O、乙酸、叔丁醇、非质子性溶剂或者它们的混合物。3. A method for synthesizing porcine pheromone as claimed in claim 1, characterized in that said solvent is H 2 O, acetic acid, tert-butanol, aprotic solvent or their mixture. 4、一种如权利要求1所述的猪外激素的合成方法,其特征是所述的有机溶剂是非质子性溶剂、醇类溶剂或者它们的混合物。4. A method for synthesizing porcine pheromone as claimed in claim 1, characterized in that said organic solvent is an aprotic solvent, an alcoholic solvent or a mixture thereof. 5、一种如权利要求1所述的猪外激素的合成方法,其特征是所述的非质子性溶剂是CH2Cl2、CHCl3、CCl4、1,2-二氯乙烷、四氢呋喃、乙醚、1,4-二噁烷、乙腈、丙酮、石油醚、正己烷、苯、甲苯、二甲亚砜、N,N-二甲基甲酰胺、吡啶或者它们的混合物。5. A method for synthesizing porcine pheromone as claimed in claim 1, characterized in that said aprotic solvent is CH 2 Cl 2 , CHCl 3 , CCl 4 , 1,2-dichloroethane, tetrahydrofuran , ether, 1,4-dioxane, acetonitrile, acetone, petroleum ether, n-hexane, benzene, toluene, dimethylsulfoxide, N,N-dimethylformamide, pyridine or their mixtures. 6、一种如权利要求1所述的猪外激素的合成方法,其特征是所述的醇类溶剂是甲醇、乙醇、丙醇、异丙醇、丁醇、异丁醇、仲丁醇、叔丁醇、二甘醇、丙三醇或者它们的混合物。6, a kind of synthetic method of porcine pheromone as claimed in claim 1 is characterized in that described alcoholic solvent is methanol, ethanol, propanol, isopropanol, butanol, isobutanol, sec-butanol, tert-butanol, diethylene glycol, glycerol or mixtures thereof.
CNB2007100374029A 2007-02-09 2007-02-09 Method of synthesizing pig ectohormone Expired - Fee Related CN100482675C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2007100374029A CN100482675C (en) 2007-02-09 2007-02-09 Method of synthesizing pig ectohormone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2007100374029A CN100482675C (en) 2007-02-09 2007-02-09 Method of synthesizing pig ectohormone

Publications (2)

Publication Number Publication Date
CN101012264A true CN101012264A (en) 2007-08-08
CN100482675C CN100482675C (en) 2009-04-29

Family

ID=38700004

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2007100374029A Expired - Fee Related CN100482675C (en) 2007-02-09 2007-02-09 Method of synthesizing pig ectohormone

Country Status (1)

Country Link
CN (1) CN100482675C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102443038A (en) * 2011-12-13 2012-05-09 浙江神洲药业有限公司 Preparation method of compound 6 beta, 19 beta-epoxy-4-androstene-3, 17-dione
CN102212101B (en) * 2009-03-13 2013-01-16 淮北煤炭师范学院 Method for preparing dihydrocholesterol and cholestanone
CN112778390A (en) * 2021-01-22 2021-05-11 厦门欧瑞捷生物科技有限公司 Synthesis method of androstenone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1221563C (en) * 2003-07-16 2005-10-05 中国科学院上海有机化学研究所 Cleaning production technique of 16-dehydro pregnenetrolone and its same kind compound
CN100387611C (en) * 2006-02-23 2008-05-14 中国科学院上海有机化学研究所 A class of 16α-bromosteroid compounds and their synthetic methods

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102212101B (en) * 2009-03-13 2013-01-16 淮北煤炭师范学院 Method for preparing dihydrocholesterol and cholestanone
CN102443038A (en) * 2011-12-13 2012-05-09 浙江神洲药业有限公司 Preparation method of compound 6 beta, 19 beta-epoxy-4-androstene-3, 17-dione
CN112778390A (en) * 2021-01-22 2021-05-11 厦门欧瑞捷生物科技有限公司 Synthesis method of androstenone

Also Published As

Publication number Publication date
CN100482675C (en) 2009-04-29

Similar Documents

Publication Publication Date Title
US9683007B2 (en) Methods for the purification of deoxycholic acid
CN106589037A (en) Method for preparing progesterone and derivatives thereof
CN109776644A (en) A kind of synthetic method of progesterone
CN102875629B (en) Synthetic method of ulipristal acetate
CN100482675C (en) Method of synthesizing pig ectohormone
CN112062805B (en) High-efficiency delta9,11Process for the preparation of (E) -canrenone
CN103694306B (en) A kind of method of budesonide S isomers ofthe R isomer
CN101857624A (en) Preparation process of desogestrel and novel intermediate compound thereof
CN101434632B (en) A kind of preparation method of 3α, 7α-dihydroxy-5β-cholanic acid
CN104725460B (en) Male steroid-4-alkene-6 ��, the preparation method of 19-ring oxygen-3,17-diketone
CN102532233A (en) Preparation process for desogestrel and novel intermediate compound thereof
CN104098640A (en) Progesterone preparation method
MX2008000936A (en) Process for the production of 3-oxo-pregn-4-ene-21,17-carbolacton es by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihyd roxyandrostanes.
CN1962680B (en) A class of 20-hydroxyl-16α-bromo-steroidal compounds, synthesis method and use thereof
Shao et al. Synthesis of hupehenols A, B, and E from protopanaxadiol
CN102225960B (en) Preparation method of allylestrenol
CN106478757B (en) 3 α of one kind, 7-6 α of alpha-dihydroxy-ethyl cholanic acid preparation method
CN102964418B (en) Preparation technology of desogestrel and new intermediate compound thereof
CN105418566B (en) A kind of synthetic method of ambrox
CN105481924A (en) Preparation method for progesterone
CA2690177C (en) Process for the preparation of 17-(3-hydroxypropyl)-17-hydroxysteroids
CN103145787A (en) Novel preparation method of ulipristal acetate key intermediate
Bull et al. Intramolecular cyclisation routes to cyclopenta [14, 15]-19-norsteroids
CN108129536A (en) A kind of preparation method of Dexamethasone Intermediate
AT271759B (en) Process for the production of new 1,2β-methylene steroids

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090429

Termination date: 20150209

EXPY Termination of patent right or utility model